Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153035 · ClinicalTrials.gov registry record · NA
Excision Followed by Radiofrequency Ablation for Breast Cancer
A NA study of Breast Cancer, sponsored by University of Arkansas.
- Active
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 6
- Study locations
NCT01153035: Active NA study of Breast Cancer, sponsored by University of Arkansas.
NCT01153035 is a NA study of Breast Cancer that is active but no longer recruiting, run by University of Arkansas. The registered enrollment target is 104 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01153035, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by University of Arkansas.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpectomy), immediately following routine surgical resection of the tumor, radiofrequency energy (RFA) is applied to the wall (bed) of the fresh lumpectomy cavity, thus extending tumor free margin radially beyond the volume of the resected specimen.
Conditions Studied
Interventions
- DEVICE Radiofrequency Ablation
Study Locations (6)
Arizona
- University of Arizona - Tucson
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
California
- Sharp Oncology (Comprehensive Breast Care of San Diego) - San Diego
Colorado
- Comprehensive Breast Care of Denver - Denver
Kansas
- The University of Kansas Cancer Center - Westwood
New York
- Columbia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2010-06 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01153035
The ClinicalTrials.gov registry entry for NCT01153035 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency Ablation is the first listed.
NCT01153035 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Arizona, Arkansas, California.
Frequently Asked Questions
What is clinical trial NCT01153035 about?
NCT01153035 is a clinical study titled "Excision Followed by Radiofrequency Ablation for Breast Cancer". The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpec...
What is the current status of trial NCT01153035?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2010-06. Estimated completion is 2027-06.
What conditions does trial NCT01153035 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01153035?
The interventions under investigation include: Radiofrequency Ablation (DEVICE).
Who is sponsoring clinical trial NCT01153035?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01153035 being conducted?
This trial has 6 study locations across Arizona, Arkansas, California, Colorado, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.